pirarubicin and Paranasal-Sinus-Neoplasms

pirarubicin has been researched along with Paranasal-Sinus-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for pirarubicin and Paranasal-Sinus-Neoplasms

Article	Year
Intraarterial infusion of 4'-O-tetrahydropyranyl-adriamycin for head and neck tumors. The Japanese journal of antibiotics, 1984, Volume: 37, Issue:6 THP-adriamycin was administered in a dose of 5 to 20 mg, 3 times a week, and the results showed 4 cases of CR, 5 cases of PR, 3 cases of MR and 2 cases of NC with the accumulated total dose of less than 100 mg. Histological effects were slight in a total dose of less than 50 mg, while the effects appeared in a total dose of 60 to 70 mg and further effects were obtained after about 1 week of the termination of the therapy. Leukopenia occurred in 6 of 14 cases. The side effects of THP-adriamycin were milder than those of ADM. Topics: Aged; Carcinoma, Squamous Cell; Doxorubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Male; Maxillary Sinus Neoplasms; Middle Aged; Mouth Neoplasms; Paranasal Sinus Neoplasms	1984

Article

Year

Intraarterial infusion of 4'-O-tetrahydropyranyl-adriamycin for head and neck tumors.

The Japanese journal of antibiotics, 1984, Volume: 37, Issue:6

THP-adriamycin was administered in a dose of 5 to 20 mg, 3 times a week, and the results showed 4 cases of CR, 5 cases of PR, 3 cases of MR and 2 cases of NC with the accumulated total dose of less than 100 mg. Histological effects were slight in a total dose of less than 50 mg, while the effects appeared in a total dose of 60 to 70 mg and further effects were obtained after about 1 week of the termination of the therapy. Leukopenia occurred in 6 of 14 cases. The side effects of THP-adriamycin were milder than those of ADM.

Topics: Aged; Carcinoma, Squamous Cell; Doxorubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Male; Maxillary Sinus Neoplasms; Middle Aged; Mouth Neoplasms; Paranasal Sinus Neoplasms

1984